from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2258c/-

LFCtreatmentdescriptionclass of inhibitor

-0.696

Amikacinug/mL Amikacintranslation

-0.151

Cap5-10ug/mL Capreomycintranslation

-0.088

Rox10-50 ug/mL Roxithromycintranslation

-0.147

SM2-5 ug/mL Streptomycintranslation

-0.237

Tet5-10 ug/mL Tetracyclinetranslation

-0.490

Rif0.2-5ug/mL Rifampicintranscription

0.083

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.008

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.082

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.375

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.794

Clofazimine10-13 ug/mL Clofaziminerespiration

0.035

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.024

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.636

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.300

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.078

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.649

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.048

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.902

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.621

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.407

KCN5-20 ug/mL Potassium cyaniderespiration

-0.548

NaN30.2-2 mM Sodium aziderespiration

0.809

Nigericin50 uM Nigericinrespiration

-0.774

TRC10-150 ug/mL Triclosanrespiration

-1.566

TRZ10-25 ug/mL Thioridazinerespiration

-2.087

Valinomycin0.5-10 uM Valinomycinrespiration

1.210

ZnSO42 mM ZnSO4respiration

-0.635

menadione6-10 ug/mL Menadionerespiration

-0.057

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.351

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.030

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.235

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.608

NRP_1Non-replicating persistence stage 1dosRassociated

0.508

Amp0.2mg/mL AmpicillincellWall

0.361

Cephalexin20-100 ug/mL CephalexincellWall

0.366

Cerulenin0.32-5 ug/mL CerulenincellWall

0.272

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.498

EMB10-20 ug/mL EthambutolcellWall

1.576

Eta12-40 ug/mL EthionamidecellWall

1.835

INH0.2-0.4 ug/mL IsoniazidcellWall

2.012

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.021

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.193

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.026

BZA0.12 mg/mL BenzamidearomaticAmides

-0.060

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.257

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.409

H2O24 mM hydrogen peroxideDNAdamaging

0.382

Levo10 ug/mL LevofloxacinDNAdamaging

0.936

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.873

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.305

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.752

UVUV-irradiationDNAdamaging

-1.012

ARP41-4 ug/mL Antitubercular compound ARP4?

0.455

Antimycin12.5-50 ug/mL Antimycin A?

0.144

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.382

PA_110-50 ug/mL Antitubercular compound PA-1?

0.304

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.414

PA8240.2-2 ug/mL PA-824?

-1.176

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.157

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.325

Verapamil50 uM Verapamil?

-0.116

mercaptoethanol2 mM 2-Mercaptoethanol?

0.214

methoxatin10-20 ug/mL Methoxatin?